Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Waiting For Bigger Bids?

Published 06/22/2017, 03:25 AM
Updated 07/09/2023, 06:31 AM

There are several stocks in “holding patterns” due to announced M&A deals. A company may have accepted an offer to be acquired but that won’t stop the speculators from paying an even higher price in anticipation of a better bid coming from a “white knight.”

The most obvious instance for this is Whole Foods (WFM) which traded $43.64 on Monday, June 19 following the Friday, June 16 news that it would be acquired by Amazon (AMZN) for $42 per share. The $1.64 over the deal price was Wall Street’s way of saying a higher bid could be coming, but will it?

The WFM and AMZN deal has a break up fee of $400M which would have to be paid to AMZN, so at 2.9% of the total deal it is not out of the question. There has been plenty of speculation about private equity names coming in and making a stronger offer. That bigger bid could make Amazon pay a higher price, but it could also draw the ire of Jeff Bezos and that isn’t a spot I would want to be in.

The end result is you have to expect that bigger bid if you are buying WFM here.

A Better Play

Xcerra (XCRA) was added to my Stocks Under $10 Investor portfolio on February 15 at about $7.82. The stock was a Zacks Rank #1 (Strong Buy) at the time as earnings estimates were trending higher. Revenue was projected to grow around 11% and the price to book multiple was only a fraction of the industry average.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

On April 10 the company announced that it would be acquired by Unic Capital Management for $10.25 per share. The deal needs to be approved and that has yet to happen, but the stock is still trading well below the deal price.

What is more, XCRA reported a very good quarter on June 1, topping estimates on top and on the bottom line.

A Missed Opportunity

Another stock in the service that I manage was being acquired and traded above the announced price. Synernon Medical (ELOS) traded up to $11.25 when the announced deal price was only $11. The company was given some time to find a superior bid, but no other bidder materialized. The stock slide into the expiration of the “go-shop” period and now I am holding this stock into the deal as it has recovered to trade within a dime of the deal price.



Xcerra Corporation (XCRA): Free Stock Analysis Report

Whole Foods Market, Inc. (NASDAQ:WFM

Amazon.com, Inc. (NASDAQ:AMZN

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.